Executive Vice President and Chief of Clinical Affairs · Prelude Therapeutics Inc (PRLD)

Deborah Morosini

FY2020 is the first fiscal year CompBrief holds for Deborah Morosini as a named executive officer of Prelude Therapeutics; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$3,921,302

Salary $194,466Stock awards $0

3rd of 6 named executive officers at Prelude Therapeutics by FY2020 total.

6 named officers on file for Prelude Therapeutics, FY2020

Deborah Morosini’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 2 equity grants, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Prelude Therapeutics’s whole pay program stands against its peers

  • Prelude Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on PRLD→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 29, 2021 (DEF 14A).

Free

Get Deborah Morosini’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Deborah Morosini compensation by year

Prelude Therapeutics Summary Compensation Table · the one fiscal year held
In US dollars, as Prelude Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020
Salary$194,466
Bonus$0
Stock awards$0
Option awards$3,594,492
Non-equity incentive$132,344
Pension and deferred compensation$0
All other$0
Total$3,921,302

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Prelude Therapeutics Inc DEF 14A filed April 29, 2021, accession 0001193125-21-140361, and prior-year filings.

How this page was built: the Prelude Therapeutics Inc filed document, accession 0001193125-21-140361. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2021.

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
Option324,224—$12.85

Per the Outstanding Equity Awards at Fiscal Year-End table in Prelude Therapeutics Inc's FY2020 proxy; value at the fiscal year-end close, as the company printed it.

Prelude Therapeutics’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Krishna VaddiChief Executive Officer$11,632,464
Christopher PierceExecutive Vice President and Chief of Business Operations$3,930,865
Deborah Morosini · this pageExecutive Vice President and Chief of Clinical Affairs$3,921,302
Peggy ScherleChief Scientific Officer$2,690,241
Andrew CombsEVP and Head of Chemistry$2,016,063
Brian PiperFormer Chief Financial Officer$1,961,340

The full Prelude Therapeutics compensation record

free company brief

This page is one person within Prelude Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Prelude Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Deborah Morosini's compensation dossier · One-time report. No refunds.